Biotech · Private company · Los Altos, CA, US
Quadriga Biosciences, Inc.
Track this companyFree. Adds Quadriga Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials2
- Study Assessing QBS72S For Treating Brain MetastasesPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 16, 2022ClinicalTrials.gov NCT05305365 · fetched Nov 12, 2026
- INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)PHASE2 · RECRUITING · started Feb 9, 2017ClinicalTrials.gov NCT02977780 · fetched Nov 12, 2026
NIH awards2
- Phase 1b/2a Trial of QBS-72S for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Patients with Unmethylated MGMT PromotersFiscal year 2025 · $1.3MNIH RePORTER 5R44CA174129-06 · fetched Nov 12, 2026
- QBS10072S for the Treatment of Brain Metastatic Triple-Negative Breast CancerFiscal year 2024 · $702.5KNIH RePORTER 5R44CA257579-03 · fetched Nov 12, 2026